Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rocchiccioli

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmatherapeutica|January 1, 1983
Oxatomide plasma levels in man during chronic dosingB H Davies, K Rocchiccioli
Thorax|August 1, 1981
Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levelsE H Walters, A Cockroft, T Griffiths, et al.
Respiratory Medicine|February 5, 2003
Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum ScaleN K Leidy, J K Schmier, M K C Jones, et al.
Respiratory Medicine|February 5, 2003
The role of the novel D2/beta2-agonist, Viozan (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigationL C Laursen, A Lindqvist, T Hepburn, et al.
British Medical Journal (Clinical Research Ed.)|February 20, 1982
Survey of pulmonary tuberculosis in south and west Wales (1976-8)R D Monie, A M Hunter, K Rocchiccioli, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmatherapeutica|January 1, 1983
Oxatomide plasma levels in man during chronic dosingB H Davies, K Rocchiccioli
Thorax|August 1, 1981
Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levelsE H Walters, A Cockroft, T Griffiths, et al.
Respiratory Medicine|February 5, 2003
Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum ScaleN K Leidy, J K Schmier, M K C Jones, et al.
Respiratory Medicine|February 5, 2003
The role of the novel D2/beta2-agonist, Viozan (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigationL C Laursen, A Lindqvist, T Hepburn, et al.
British Medical Journal (Clinical Research Ed.)|February 20, 1982
Survey of pulmonary tuberculosis in south and west Wales (1976-8)R D Monie, A M Hunter, K Rocchiccioli, et al.
Pageof 1